Phase I Study of SU011248 [sunitinib] in Combination With Paclitaxel/Carboplatin in Patients With Advanced Solid Malignancies.
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2009
At a glance
- Drugs Carboplatin; Paclitaxel; Sunitinib
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Pfizer
- 21 Nov 2009 New source identified and integrated (M.D. Anderson Cancer Center record 2006-0414).
- 21 Nov 2009 Planned number of patients changed from 50 to 72 as reported by M.D. Anderson Cancer Center record.
- 14 Jul 2009 Actual patient number (43) added as reported by ClinicalTrials.gov.